Insulet Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of Insulet Corp Company

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Insulet Corp Info



Ticker SymbolPODD

Company nameInsulet Corp

IPO dateMay 15, 2007

CEOMs. Ashley Mcevoy

Number of employees3900

Security typeOrdinary Share

Fiscal year-endMay 15

Address100 Nagog Park

CityACTON

Stock exchangeNASDAQ Global Select Consolidated

CountryUnited States of America

Postal code01720-3440

Phone19786007000

Websitehttps://www.omnipod.com

Ticker SymbolPODD

IPO dateMay 15, 2007

CEOMs. Ashley Mcevoy

Company Executives of Insulet Corp



Name

Name/Position

Position

Shareholding

Change

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

--

Mr. Prem Singh

Senior Vice President - Global Operations

3.56K

-16.16%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

Name

Name/Position

Position

Shareholding

Change

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

By BusinessUSD

Name

Revenue

Proportion

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

By RegionUSD

Name

Revenue

Proportion

United States

463.30M

71.38%

All Other

185.80M

28.62%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

Shareholding Stats

Updated: Tue, Aug 19

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Other

60.68%

Shareholders

Proportion

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Other

60.68%

Shareholder Types

Shareholders

Proportion

Investment Advisor

64.61%

Investment Advisor/Hedge Fund

23.75%

Hedge Fund

5.78%

Research Firm

2.96%

Pension Fund

2.15%

Sovereign Wealth Fund

1.60%

Bank and Trust

1.22%

Individual Investor

0.30%

Private Equity

0.09%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

1522

71.86M

102.08%

-3.62M

2025Q2

1541

72.80M

103.47%

-3.81M

2025Q1

1569

72.82M

103.50%

-3.52M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

8.68M

12.33%

+38.89K

+0.45%

Jun 30, 2025

Fidelity Management & Research Company LLC

6.86M

9.74%

-271.19K

-3.80%

Jun 30, 2025

Capital Research Global Investors

4.74M

6.73%

-1.34M

-22.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.35M

6.18%

-13.40K

-0.31%

Jun 30, 2025

State Street Investment Management (US)

3.06M

4.34%

+32.74K

+1.08%

Jun 30, 2025

Baillie Gifford & Co.

2.14M

3.03%

-115.69K

-5.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.93M

2.74%

+58.31K

+3.12%

Jun 30, 2025

ClearBridge Investments, LLC

1.54M

2.18%

+56.63K

+3.83%

Jun 30, 2025

American Century Investment Management, Inc.

1.31M

1.86%

+157.07K

+13.63%

Jun 30, 2025

Fidelity International

1.13M

1.61%

-155.38K

-12.09%

Jun 30, 2025

Related ETFs



Updated: Mon, Oct 6

Name

Proportion

Langar Global HealthTech ETF

6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.97%

Goldman Sachs Future Health Care Equity ETF

4.91%

Global X HealthTech ETF

4.42%

Fidelity Digital Health ETF

4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

3.4%

Congress SMid Growth ETF

2.99%

iShares U.S. Medical Devices ETF

2.74%

iShares Health Innovation Active ETF

2.64%

FT Raymond James Multicap Growth Equity ETF

2.54%

Langar Global HealthTech ETF

Proportion6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proportion4.97%

Goldman Sachs Future Health Care Equity ETF

Proportion4.91%

Global X HealthTech ETF

Proportion4.42%

Fidelity Digital Health ETF

Proportion4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

Proportion3.4%

Congress SMid Growth ETF

Proportion2.99%

iShares U.S. Medical Devices ETF

Proportion2.74%

iShares Health Innovation Active ETF

Proportion2.64%

FT Raymond James Multicap Growth Equity ETF

Proportion2.54%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data